Growth Metrics

BioNTech SE (BNTX) Non-Current Debt: 2018-2024

Historic Non-Current Debt for BioNTech SE (BNTX) over the last 2 years, with Dec 2024 value amounting to $50.1 million.

  • BioNTech SE's Non-Current Debt rose 20.05% to $50.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was $50.1 million, marking a year-over-year increase of 20.05%. This contributed to the annual value of $50.1 million for FY2024, which is 20.05% up from last year.
  • According to the latest figures from Q4 2024, BioNTech SE's Non-Current Debt is $50.1 million, which was up 20.05% from $41.7 million recorded in Q4 2023.
  • In the past 5 years, BioNTech SE's Non-Current Debt ranged from a high of $315.7 million in Q3 2021 and a low of $6.2 million during Q4 2022.
  • Its 3-year average for Non-Current Debt is $122.0 million, with a median of $112.3 million in 2024.
  • Per our database at Business Quant, BioNTech SE's Non-Current Debt slumped by 96.94% in 2022 and then soared by 570.79% in 2023.
  • Over the past 5 years, BioNTech SE's Non-Current Debt (Quarterly) stood at $275.4 million in 2020, then fell by 26.19% to $203.3 million in 2021, then plummeted by 96.94% to $6.2 million in 2022, then skyrocketed by 570.79% to $41.7 million in 2023, then climbed by 20.05% to $50.1 million in 2024.
  • Its Non-Current Debt was $50.1 million in Q4 2024, compared to $41.7 million in Q4 2023 and $6.2 million in Q4 2022.